1. Stocks
    2. /
  2. Clinuvel Pharmaceuticals (ASX: CUV)
    3. /

Clinuvel Pharmaceuticals (ASX: CUV) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Clinuvel Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Clinuvel Pharmaceuticals (ASX: CUV)
    Latest News

    A young female investor sits in her home office looking at her ipad and smiling as she sees the QBE share price rising
    Broker Notes

    Buy these 4 ASX 300 shares, say top brokers

    | Bronwyn Allen

    Market analysts have upgraded their ratings on these four ASX 300 shares today.

    Read more »

    Couple looking at their phone surprised, symbolising a bargain buy.
    Broker Notes

    Brokers name 3 ASX shares to buy now

    | James Mickleboro

    Here's why brokers are feeling bullish about these three shares this week.

    Read more »

    a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
    Healthcare Shares

    Broker says this ASX 300 healthcare share can rise 60% in 12 months

    | James Mickleboro

    Here's why this broker is feeling exceptionally bullish on this share.

    Read more »

    Smiling elderly couple looking at their superannuation account, symbolising retirement.
    Share Gainers

    Why Clinuvel, SRG, Strike Energy, and Tietto shares are racing higher today

    | James Mickleboro

    these ASX shares are having a strong session on Thursday. But why?

    Read more »

    Stressed, unhappy and tired scientist with a headache working on a computer in a lab. Worried, anxious and frustrated pathologist, researcher and doctor struggling with burnout, tension and strain.
    Healthcare Shares

    Down 25% in a month, is this ASX 300 company about to sue the UK Government?

    | James Mickleboro

    What's going on at this healthcare share?

    Read more »

    A happy looking woman holding a colourful umbrella against a grey cloudy sky.
    Best Shares

    Top ASX shares to buy in July 2023

    | Motley Fool Staff

    Could these hand-picked shares be the portfolio boosters we need to ring in the new financial year?

    Read more »

    A scientist examining test results.
    Opinions

    Down 35% in a year, is the Imugene share price a buying opportunity right now?

    | Mitchell Lawler

    Is a 35% discount enticing enough to invest in this clinical-stage biotech. Here's my take.

    Read more »

    A young man sits at his desk working on his laptop with a big smile on his face.
    Opinions

    10 stocks for 10 years: How I would invest $10,000 in ASX shares right now

    | Mitchell Lawler

    I won't be conned into holding a huge stash of cash. Here are 10 investments I'd rather make for long…

    Read more »

    Businessman at the beach building a wall around his sandcastle, signifying protecting his business.
    Opinions

    3 defensive ASX shares surrounded by wide moats I'd buy with $5,000

    | Mitchell Lawler

    Investors can secure massive returns over the long term if a company holds a sustainable competitive advantage.

    Read more »

    A worried man holds his head and look at his computer.
    Share Fallers

    Why Clinuvel, Cogstate, Omni Bridgeway, and Westgold shares are sinking

    | James Mickleboro

    These ASX shares are ending the week in a disappointing fashion...

    Read more »

    Five people are leaping in the shallows of the beach water as sunset shines gold on them.
    52-Week Highs

    5 ASX 200 shares rocketing to new 52-week highs on Tuesday

    | Brooke Cooper

    These stocks are making the most of the ASX 200's strong start to 2023.

    Read more »

    Arrows pointing upwards with a man pointing his finger at one.
    52-Week Highs

    4 ASX All Ordinaries shares hitting new 52-week highs today

    | Brooke Cooper

    Do you know the coal and healthcare shares trading at 12-month highs?

    Read more »

    Frequently Asked Questions

    Yes, Clinuvel Pharmaceuticals has historically paid one unfranked shareholder dividend a year.

    Clinuvel Pharmaceuticals generally pays its shareholder dividend in September.

    Clinuvel Pharmaceuticals does not have a dividend reinvestment plan.

    Clinuvel Pharmaceuticals Limited listed on the ASX on 13 February 2001.

    CUV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Clinuvel Pharmaceuticals

    Clinuvel Pharmaceuticals Ltd (ASX: CUV) is an Australian-based global biopharmaceutical company developing drugs for the treatment of genetic and vascular disorders. Its principal product SCENESSE is a drug for an inherited disorder, erythropoietic protoporphyria, that causes an intolerance to light.

    Its pioneering work aims at preventing the symptoms of skin diseases related to exposure to UV radiation and at repigmentation of the skin due to depigmentation disorders. Geographically, the company derives the majority of its revenue from its US and European markets.

     

    Profile

    since

    Note